Taitel Haya 4

What Happened

• Taitel Haya, a director of Entera Bio Ltd. (ENTX), reported a purchase of 7,500 common shares on 2026-02-10. The filing lists a weighted average price of $1.48 per share for a total acquisition value of $11,100. The transaction type is reported as "P" (purchase), described as open market or private purchase.

Key Details

• Transaction date: 2026-02-10; Form 4 filed: 2026-02-11 (within the usual reporting window).
• Price: weighted average $1.48 per share; purchases occurred at prices ranging from $1.47 to $1.4799 (per footnote).
• Shares acquired: 7,500; total reported cost: $11,100.
• Shares owned after transaction: Not disclosed in this filing.
• Notable footnote: The price is a weighted average; the reporting person can provide a breakdown of purchases by individual price within the $1.47–$1.4799 range on request.
• Transaction code: P = Purchase (open market or private purchase as reported).

Context

• This is a small-value insider purchase that may be of interest to retail investors because purchases by insiders can signal confidence, but the filing does not state motive. The filing is timely and provides a price range rather than per-trade prices; contact the company or SEC staff for a detailed price breakdown if needed.